Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — 9M 2018 Earnings Presentation
10 slides from Rhon-klinikum's earnings presentation, Nov 9, 2018
Slide 1: Results for the First Nine Months of 2018
Results for the First Nine Months of 2018 9 November 2018 Stephan Holzinger Julian Schmitt RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any
Slide 3: Highlights of Q3 2018
Highlights of Q3 2018 RHÖN delivers as promised on key figures despite a challenging regulatory landscape Revenues €928.5m/EBITDA margin 11.0%/net profit margin 5.1% Inpatient and outpatient cases rise to 644,177 (+2.0%) Effects from UKGM separate accounting contract can be accounted for as
Slide 4: Key P&L figures First Nine Months of 2018
Key P&L figures First Nine Months of 2018 Effectiveness of separate accounting provides a Performance1) vs. 9M 2018 positive € 20m one-off EBITDA effect in € millions 9M 2017 Revenue 928.5 100.0% 2.9% o Solid revenue increase2) of +2.9% despite slight decline in inpatient cases and tough regulatory
Slide 5: Core balance sheet positions as of 30 September 2018
Core balance sheet positions as of 30 September 2018 €1,482m €1,482m 66.5% €986m Non-current assets €1,156m 78.0% Equity €496m 33.5% €17m Non-current liabilities 1.2% Current assets €309m Current liabilities 20.8% €147m cash Assets Equity & liabilities multi-tier Continued strong cash position and
Slide 6: Guidance: Regulatory Perspective & Financial Outlook
Regulatory Perspective & Financial Outlook First Half-Year of 2018 First insights into regulation for 2019... General wage sum increase (initial DRG inflator) +2.65% as an initial DRG inflator 2.80% 2.95% 2.97% 3,0% 3.0% Catalogue effect again with price cuts on material 2.00% 2.65% 2.50% 2.50%
Slide 7: Financial Calendar for FY 2019
Appendix Financial Calendar for FY 2019 22 February 2019 Preliminary results for financial year 2018 Conference call 29 March 2019 Publication of annual financial report 2018 Annual Press Conference 10 April 2019 Capital Markets Day (Campus Bad Neustadt) 3 May 2019 Publication of interim rep
Slide 8: Price Regulation in 2019 at a Glance
Appendix Price Regulation in 2019 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2019: +2.65%
Slide 9: Shareholder base
Appendix Shareholder base Shareholder Structure as of 31 October 2018, according to the most recent notifications of voting rights at that time 25.1% Asklepios 24.7%1) 24.7% Free Float 5.2% 75.3% Landeskrankenhilfe Strategic Investors 5.4% 25.0% Ingeborg Münch B. Braun 14.6% Eugen Münch/HCM SE 1) Sh
Slide 10: IR contact information
Appendix IR contact information Contact Julian Schmitt Head of Investor Relations & Treasury tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG – Results for the First Nine Months of 2018 10